/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Endovasc Inc.\n \n\n\n\n\n
Nov 20 8:49 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Jul 06, 2006 2:01 PM EDT
\n\n \n American Oriental Bioengineering Inc. Added to Russell 3000(R) Index and Endovasc Receives Issue Notification for U.S. Patent Protecting its Muscle Mass Technology - US Equity News\n \n \n
\n\n Jun 27, 2006 1:28 PM EDT
\n\n \n Analytical Bio-Chemistry Laboratories to Develop Liprostin Assays for Endovasc's Phase III Trial - GlobeNewswire\n \n \n
\n\n Apr 28, 2005 12:14 PM EDT
\n\n \n InKine at the 2nd Annual Global Health Conference, UBDE Announces Multiple Agreements for Regenerative Tissue Technologies and Files Provisional Patent! - US Equity News\n \n \n
\n
\n\n");